KRAS and prostate cancer: We have obtained similar results in PC3 prostate cancer xenografts (see Additional file 1: Figure S 1) indicating that these are likely universal responses of human epithelial tumours to IR that are independent of K-Ras mutation status and LKB1 or p53 function.